BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26223536)

  • 1. Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.
    Mackie SL; Taylor JC; Haroon-Rashid L; Martin S; Dasgupta B; Gough A; Green M; Hordon L; Jarrett S; Pease CT; Barrett JH; Watts R; Morgan AW; ;
    Arthritis Res Ther; 2015 Jul; 17(1):195. PubMed ID: 26223536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
    Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
    Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
    Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
    Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
    J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association.
    Prieto-Peña D; Remuzgo-Martínez S; Ocejo-Vinyals JG; Atienza-Mateo B; Muñoz-Jiménez A; Ortiz-Sanjuán F; Romero-Yuste S; Moriano C; Galíndez-Agirregoikoa E; Miranda-Filloy JA; Blanco R; Gualillo O; Martín J; Castañeda S; López-Mejías R; González-Gay MA
    Semin Arthritis Rheum; 2020 Oct; 50(5):897-901. PubMed ID: 32898759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
    Prieto-Peña D; Remuzgo-Martínez S; Ocejo-Vinyals JG; Atienza-Mateo B; Genre F; Muñoz-Jimenez A; Ortiz-Sanjuán F; Romero-Yuste S; Moriano C; Galindez-Agirregoikoa E; Calvo I; Ortego-Centeno N; Álvarez-Rivas N; Miranda-Filloy JA; Llorente I; García-García J; Blanco R; Gualillo O; Martin J; Castañeda S; Lopez-Mejías R; González-Gay MA
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):21-26. PubMed ID: 33734973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis.
    Amoli MM; Shelley E; Mattey DL; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2001 Jul; 28(7):1600-4. PubMed ID: 11469468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis.
    Amoli MM; Gonzalez-Gay MA; Zeggini E; Salway F; Garcia-Porrua C; Ollier WE
    J Rheumatol; 2004 Dec; 31(12):2413-7. PubMed ID: 15570643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA DRB1 polymorphism in rhizomelic pseudo-polyarthritis and Horton disease].
    Labbe P; Flipo RM; Fajardy I; Hachulla E; Houvenagel E; Hatron PY; Duquesnoy B; Danze PM
    Rev Med Interne; 1995; 16(10):778-81. PubMed ID: 8525160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy.
    Salvarani C; Boiardi L; Mantovani V; Ranzi A; Cantini F; Olivieri I; Viggiani M; Bragliani M; Macchioni P
    J Rheumatol; 1999 Nov; 26(11):2395-9. PubMed ID: 10555899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
    Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
    J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
    Gonzalez-Gay MA; Rueda B; Vilchez JR; Lopez-Nevot MA; Robledo G; Ruiz MP; Fernández O; Garcia-Porrua C; Gonzalez-Escribano MF; Martín J
    Rheumatology (Oxford); 2007 Mar; 46(3):431-4. PubMed ID: 17003171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis.
    Morgan AW; Robinson JI; Barrett JH; Martin J; Walker A; Babbage SJ; Ollier WE; Gonzalez-Gay MA; Isaacs JD
    Arthritis Res Ther; 2006; 8(4):R109. PubMed ID: 16846526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
    Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
    Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
    Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
    Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.
    Carmona FD; Mackie SL; Martín JE; Taylor JC; Vaglio A; Eyre S; Bossini-Castillo L; Castañeda S; Cid MC; Hernández-Rodríguez J; Prieto-González S; Solans R; Ramentol-Sintas M; González-Escribano MF; Ortiz-Fernández L; Morado IC; Narváez J; Miranda-Filloy JA; ; Beretta L; Lunardi C; Cimmino MA; Gianfreda D; Santilli D; Ramirez GA; Soriano A; Muratore F; Pazzola G; Addimanda O; Wijmenga C; Witte T; Schirmer JH; Moosig F; Schönau V; Franke A; Palm Ø; Molberg Ø; Diamantopoulos AP; Carette S; Cuthbertson D; Forbess LJ; Hoffman GS; Khalidi NA; Koening CL; Langford CA; McAlear CA; Moreland L; Monach PA; Pagnoux C; Seo P; Spiera R; Sreih AG; Warrington KJ; Ytterberg SR; Gregersen PK; Pease CT; Gough A; Green M; Hordon L; Jarrett S; Watts R; Levy S; Patel Y; Kamath S; Dasgupta B; Worthington J; Koeleman BP; de Bakker PI; Barrett JH; Salvarani C; Merkel PA; González-Gay MA; Morgan AW; Martín J
    Am J Hum Genet; 2015 Apr; 96(4):565-80. PubMed ID: 25817017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis.
    Rauzy O; Fort M; Nourhashemi F; Alric L; Juchet H; Ecoiffier M; Abbal M; Adoue D
    Ann Rheum Dis; 1998 Jun; 57(6):380-2. PubMed ID: 9771216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis.
    Jacobsen S; Baslund B; Madsen HO; Tvede N; Svejgaard A; Garred P
    J Rheumatol; 2002 Oct; 29(10):2148-53. PubMed ID: 12375325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
    Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
    J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
    Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.